Back to top
more

HeartBeam (BEAT)

(Delayed Data from NSDQ)

$2.37 USD

2.37
80,877

-0.18 (-7.06%)

Updated Jul 30, 2024 04:00 PM ET

After-Market: $2.42 +0.05 (2.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (79 out of 251)

Industry: Medical Info Systems

Better trading starts here.

Zacks News

Advisory Board (ABCO) in Focus: Stock Moves 6.4% Higher

Advisory Board (ABCO) shares rose more than 6% in the last trading session, amid huge volumes.

    Why Biotelemetry (BEAT) Could Be an Impressive Growth Stock

    Biotelemetry (BEAT) seems well-positioned for future earnings growth and it is seeing rising earnings estimates as well, coupled with a solid Zacks Rank.

      The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express

      The Zacks Analyst Blog Highlights: Health Insurance Innovations, BioTelemetry, Solaredge Technologies, Aaron's and Petmed Express

        Here's Why Investors Should Buy BioTelemetry (BEAT) Now

        BioTelemetry's (BEAT) buyout of LifeWatch AG has expanded its product portfolio and customer base in the cardiac monitoring and diagnostic services space.

          BioTelemetry Hits a 52-Week High: What's Driving the Stock?

          BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.

            Tirthankar Chakraborty headshot

            New Strong Buy Stocks for August 16th

            Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday

              Top Ranked Momentum Stocks to Buy for August 16th

              Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, August 16th:

                BioTelemetry (BEAT) Q2 Earnings Top, Revenues Meet Estimates

                BioTelemetry (BEAT) rides high on all its segments in Q2. The company is also putting in efforts in product innovation through research and development.

                  BioTelemetry (BEAT) Acquires LifeWatch for $280 Million

                  BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.

                    BioTelemetry, Inc. (BEAT) in Focus: Stock Moves 6.5% Higher

                    BioTelemetry (BEAT) was a big mover last session, as the company saw its rise nearly 7% on Friday amid huge volumes.

                      Will BioTelemetry (BEAT) Continue to Surge Higher?

                      As of late, it has definitely been a great time to be an investor in BioTelemetry, Inc. (BEAT).

                        BioTelemetry (BEAT) Shows Strength: Stock Moves 8.8% Higher

                        BioTelemetry, Inc. (BEAT) shares rose almost 9% in the last trading session.

                          Patrick Anderson headshot

                          This Week's Hidden Gems: (AAOI)(BEAT)

                          Tracey Ryniec uncovers two top stocks that are flying under the radar.

                            Teladoc Continues to Grow in Booming Telehealth Industry

                            Teladoc Inc. (TDOC), a premier telehealth services provider, is rapidly expanding its business in the booming telehealth services industry.

                              The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed

                              The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and Chemed

                                Swarup Gupta headshot

                                5 Stocks to Buy for the Post-Obamacare Era

                                Insurers, hospitals and healthcare service providers with strong fundamentals would make welcome additions to your portfolio.

                                  BioTelemetry (BEAT) Looks Good: Stock Adds 7.2% in Session

                                  BioTelemetry, Inc. (BEAT) saw its shares rise above 7% in the last trading session.

                                    Tirthankar Chakraborty headshot

                                    New Strong Buy Stocks for February 24th

                                    Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday

                                      Tirthankar Chakraborty headshot

                                      New Strong Buy Stocks for August 11th

                                      Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday

                                        New Strong Buy Stocks for August 9th

                                        Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                                          David Bartosiak headshot

                                          5 Strong Stocks in Stronger Industries

                                          The market rewards strength. These are the best stocks in the best industries.

                                            Brian Hamilton headshot

                                            Top 5 Medical Service Stocks to Buy

                                            The Medical sector is one of the top performing sectors for Q3 2015, and it is expected to be a top performer in Q4 2015 too.

                                              David Bartosiak headshot

                                              Two Perfectly Timed Momentum Stock Trades

                                              These two stock ideas are showing up at the perfect time to buy.

                                                David Bartosiak headshot

                                                5 Top Performing Stocks to Buy

                                                If a stock can perform in this market, imagine how it will do when things normal out